- Venture Life, a self-care group focused on developing, manufacturing and commercialising products for the ageing population, warned that full year EBITDA will not meet current market expectations.

The group said it chose to invest significantly in support of the brands business, which together with delays in orders from some international distributors, means the margins and sales mix is expected to differ from its original projections.

In the first half, revenues increased by 28% to £7.8 million, reducing the company's loss before tax, amortisation and exceptional items to £0.1 million from £0.3 million the year before.

Jerry Randall, chief executive officer of Venture Life, said: "Our robust business model is delivering excellent organic growth, and the success of the UltraDEX acquisition is demonstrating our ability to acquire and assimilate interesting products. In this regard, I expect us to continue to explore M&A opportunities to complement our core organic growth, and drive sustainable profitability for the group over the long term."

At 8:49am: [LON:VLG] Venture Life Group Plc share price was -8p at 57.5p

Story provided by